ZILOVERTAMAB
UNII FEH7RQ7B3J

Substance Identification & Data

This profile provides standardized clinical and technical data for Zilovertamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FEH7RQ7B3J.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2485779-13-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

FEH7RQ7B3J

CAS Registry Number

2485779-13-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ZILOVERTAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C118284

National Cancer Institute reference terminology for clinical and research data.

INN ID

11636

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zilovertamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZILOVERTAMAB

Common Names & Synonyms

CIRMTUZUMAB

IMMUNOGLOBULIN G1, ANTI-(HUMAN RECEPTOR TYROSINE KINASE ROR-1) (HUMAN-MUS MUSCULUS MONOCLONAL UC-961 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL UC-961 .KAPPA.-CHAIN, DIMER

ZILOVERTAMAB [INN]

ZILOVERTAMAB [WHO-DD]